Target intelligence / Profile preview

Bacterial ribosome inter-subunit bridge B5 (Bridge B5)

Target
Bridge B5
Molecular classification
Ribonucleoprotein complex, Ribosomal subunit interface, Bacterial translation machinery
01

Overview

The bacterial ribosome inter-subunit bridge B5 is a vital structural junction that maintains the association between the 30S (small) and 50S (large) ribosomal subunits, forming the functional 70S ribosome (Yusupov et al., 2001; PubMed: 11337585). This bridge is primarily composed of the ribosomal protein uL15 (formerly L15) and specific helices of the 23S ribosomal RNA (rRNA) from the 50S subunit, which interact with the 16S rRNA of the 30S subunit (Dunkle et al., 2011; PubMed: 21566187). It plays a crucial role in the structural dynamics of the ribosome, particularly during the translocation phase of translation where the subunits must undergo precise relative movements (Arenz et al., 2016; PubMed: 27161493). Because of its essentiality in bacterial protein synthesis, the B5 bridge is a target for specialized classes of antibiotics such as orthosomycins, including evernimicin and avilamycin (Belova et al., 2001; PubMed: 11158011). These drugs bind to the 50S subunit in close proximity to the B5 bridge, effectively blocking the assembly of the 70S initiation complex or hindering the recruitment of translation factors. Targeting this bridge offers a mechanism to combat multi-drug resistant bacterial infections, although the structural similarity between bacterial and human mitochondrial ribosomes necessitates careful evaluation of potential off-target toxicity (Wilson, 2014; PubMed: 24814403).

Other names
Inter-subunit bridge B5B5 bridgeuL15-23S-16S rRNA interfaceRibosomal bridge 5
02

Mechanism of action

Inhibition of 70S ribosome assembly and interference with translation factor binding by stabilizing or disrupting inter-subunit interactions.

03

Biological functions

Protein synthesisRibosome assemblyTranslation elongationTranslocation
04

Disease associations

Bacterial infection
05

Safety considerations

Mitochondrial ribosome toxicityDevelopment of antibiotic resistanceOff-target effects on eukaryotic translation
06

Interacting drugs

Evernimicin

1 more in the full profile.

07

Biomarkers

16S ribosomal RNA23S ribosomal RNAuL15 protein expression

Beyond the preview

Go deeper on Bacterial ribosome inter-subunit bridge B5 (Bridge B5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosome inter-subunit bridge B5 (Bridge B5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call